Last reviewed · How we verify
Intraumbilical vein injection oxytocin
Intraumbilical vein injection oxytocin is a Small molecule drug developed by Eslam Mohammed Abbas. It is currently in Phase 2 development.
At a glance
| Generic name | Intraumbilical vein injection oxytocin |
|---|---|
| Sponsor | Eslam Mohammed Abbas |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Intraumbilical Oxytocin Versus Placental Cord Drainage in the Management of 3rd Stage of Labor (PHASE2)
- Prophylactic Use of Intraumbilical Vein Oxytocin Injection in The Management of Third Stage of Labor (PHASE1)
- Intraumbilical Vein Injection of Oxytocin in Routine Practice for Active Management of the Third Stage of Labor (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intraumbilical vein injection oxytocin CI brief — competitive landscape report
- Intraumbilical vein injection oxytocin updates RSS · CI watch RSS
- Eslam Mohammed Abbas portfolio CI
Frequently asked questions about Intraumbilical vein injection oxytocin
What is Intraumbilical vein injection oxytocin?
Intraumbilical vein injection oxytocin is a Small molecule drug developed by Eslam Mohammed Abbas.
Who makes Intraumbilical vein injection oxytocin?
Intraumbilical vein injection oxytocin is developed by Eslam Mohammed Abbas (see full Eslam Mohammed Abbas pipeline at /company/eslam-mohammed-abbas).
What development phase is Intraumbilical vein injection oxytocin in?
Intraumbilical vein injection oxytocin is in Phase 2.